Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Veterinary Monitoring Equipment Market Size & Share 2026-2035
Report ID: GMI5943
|
Published Date: November 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Veterinary Monitoring Equipment Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Veterinary Monitoring Equipment Market Size
The veterinary monitoring equipment market was valued at USD 641 million in 2025 and is projected to reach USD 700 million in 2026, advancing at a 9.5% CAGR (2026–2035) to USD 1.58 billion by 2035.
Veterinary Monitoring Equipment Market Key Takeaways
Market Leader: Mindray Animal Health led with over 11.1% market share in 2025.
Leading Players: Top 5 players in this market include Mindray Animal Health, IDEXX Laboratories, Midmark, Masimo Corporation, Medtronic, which collectively held a market share of 45.10% in 2025.
The veterinary monitoring equipment market is being shaped by the normalization of continuous physiologic surveillance in anesthesia, surgery, recovery, and higher-acuity outpatient care. Demand is moving beyond basic standalone devices as specialty hospitals, referral networks, research facilities, and mobile care providers seek connected systems that can support more complex workflows and a broader mix of animal species.
GMI Analyst View
Based on our review of supply-side procurement data and clinical purchasing records across key geographies, the veterinary monitoring equipment market reached USD 590 million in 2024, reflecting sustained momentum in the years immediately preceding the 2025 base year. We view this trajectory as evidence of a structural expansion in monitored veterinary care rather than a short-lived equipment replacement cycle.
Veterinary Monitoring Equipment Market Trends, Growth Drivers & GMI Forecast Outlook
Veterinary providers are increasing the intensity of monitoring per patient encounter as companion-animal care becomes more clinically sophisticated and hospital capacity expands. The forecast depends on continued investment in multi-parameter systems, portable platforms, and species-appropriate monitoring tools, while affordability and workforce constraints continue to differentiate adoption across care settings.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
The sustained rise in companion-animal ownership is reshaping the scale and clinical expectations of veterinary practice globally. As more households commit to pets across a broader range of species and life stages, monitoring equipment has migrated from a specialized surgical-suite tool into a routine component of wellness and diagnostic protocols. With 133,475 licensed veterinarians active in the U.S. alone as of 2025 [2]American Veterinary Medical Association. "U.S. Veterinarian Numbers." avma.org, the professional infrastructure available to deploy and maintain clinical monitoring hardware is at an all-time peak, providing demand absorption capacity that supports multi-year equipment procurement and refresh cycles across both hospital and clinic-level buyers.
Expenditure growth is itself being reinforced by the rapid expansion of pet insurance. U.S. gross written premiums reached USD 4.7 billion in 2024 according to the North American Pet Health Insurance Association [4]American Veterinary Medical Association. "US Pet Insurance Industry Surpasses $4B in 2024." avma.org. Insured pet owners are demonstrably more likely to authorize monitoring-intensive procedures, enabling veterinarians to adopt more thorough perioperative surveillance protocols. As insurance penetration broadens, the clinical intensity of monitoring per animal encounter is expected to rise alongside it, benefiting multi-parameter and anesthesia monitor segments that depend on procedural volume for consistent replacement cycles.
The technology transformation underway in veterinary monitoring is simultaneously expanding the product renewal cycle and the clinical footprint of monitoring equipment. Wearable sensors with extended battery performance, AI-assisted physiological alerting, and integration with practice management software are moving monitoring capability beyond traditional anesthesia and surgical applications. This convergence is particularly significant for capnography systems, pulse oximetry devices, and emerging remote telemetry platforms, all of which benefit from the combination of component miniaturization and wireless connectivity to reach clinical settings previously underserved by fixed monitoring infrastructure.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Rural and food-animal practices face a different adoption equation from specialty companion-animal hospitals. Lower specialist availability can reduce the procedure volume needed to justify advanced equipment, while limited technical staffing complicates installation, training, and preventive maintenance. The resulting constraint is not solely a question of local purchasing power; it is also a question of whether a facility can consistently use a higher-specification platform at sufficient intensity.
Financial exposure remains consequential where owners must make immediate treatment decisions. Independent practices may prioritize versatile devices with lower acquisition and service costs, even when a premium platform offers more integrated capabilities. That buying behavior can preserve demand for essential monitoring while delaying the shift toward higher-value systems.
Species-specific validation is a further constraint on product standardization. A monitor that performs reliably in small-animal anesthesia may require different calibration assumptions, sensor configurations, or clinical protocols for equine, avian, or exotic-animal use. This creates a commercial advantage for suppliers with credible veterinary validation, field support, and practical training resources.
GMI Analyst View
We see a durable bifurcation in purchasing behavior. Hospital and referral settings are likely to prioritize integrated monitoring platforms that support complex care pathways, while independent clinics will continue to favor dependable systems with clear clinical utility and manageable ownership costs. This divergence will shape product mix, channel strategy, and service requirements across the forecast period.
Veterinary Monitoring Equipment Market Segment Analysis
By Type
Vital Sign Monitors
Vital sign monitors generated USD 224 million in 2025 and are projected to reach USD 530 million by 2035. The veterinary monitoring equipment market relies on these systems as the foundational platform for routine procedural surveillance across primary care, surgery, and recovery. Their broad installed base supports recurring replacement demand, while added multi-parameter capability is gradually raising the specification level expected even in smaller clinics.
Capnography & Oximetry Systems
Capnography & oximetry systems accounted for 20.0% of the market in 2025 and are expected to advance at a 9.3% CAGR (2026–2035). Their role is strengthened by the clinical need to identify respiratory compromise during sedation and anesthesia, especially where visual observation is insufficient. Miniaturized and portable configurations are widening their relevance in field procedures and practices that are formalizing anesthesia protocols.
Anesthesia Monitors
Anesthesia monitors are projected to reach USD 285 million by 2035 and represented 18.0% of the market in 2025. Demand is tied to procedural volume and to the growing expectation that anesthesia workflows should integrate respiratory, cardiac, temperature, and blood-pressure surveillance. Higher-acuity hospitals are increasingly favoring consolidated platforms that reduce device clutter and improve visibility during complex cases.
ECG/EKG Monitors
ECG/EKG monitors generated USD 77 million in 2025 and are projected to hold an 11.4% market share by 2035. Pre-anesthetic screening, geriatric animal care, and management of breed-specific cardiac risk support adoption beyond dedicated cardiology practices. The category also benefits from integration into multi-parameter equipment, which makes cardiac monitoring more accessible in general-practice environments.
MRI Systems
MRI systems are projected to reach USD 166 million by 2035 and are forecast to grow at a 12.5% CAGR (2026–2035). Demand is concentrated in specialty and teaching-hospital settings where neurological and musculoskeletal cases justify the capital commitment and specialized workflow. Compact system configurations and expanding referral capacity are gradually widening the institutional base capable of supporting these purchases.
Other Veterinary Monitoring Equipment
Other veterinary monitoring equipment accounted for 7.0% of the market in 2025 and is projected to represent 6.6% by 2035. This category includes wearable, remote, temperature, and weight-monitoring tools that address use cases not fully served by conventional procedure-room platforms. Its strategic importance exceeds its revenue weight because connected devices can extend monitoring into post-operative, ambulatory, and home-based care.
By Application
Respiratory Monitoring
Respiratory monitoring generated USD 192 million in 2025 and is projected to account for 30.7% of the market by 2035. Its importance reflects the central role of capnography and pulse oximetry in anesthesia safety and recovery surveillance. Practices moving from intermittent checks toward continuous observation are creating a sustained demand base for respiratory-focused equipment and modules.
Multi-Parameter Monitoring
Multi-parameter monitoring held a 25.0% market share in 2025 and is forecast to expand at a 10.2% CAGR (2026–2035). Integrated platforms reduce the need to manage separate devices for ECG, oxygen saturation, temperature, blood pressure, and respiratory monitoring. This makes them particularly attractive to hospitals that need consistent workflows across operating rooms, emergency care, and recovery areas.
Cardiology
Cardiology monitoring is projected to reach USD 277 million by 2035 and represented 18.0% of the market in 2025. Demand is supported by more systematic cardiac assessment of aging companion animals and by the growing availability of specialty referral services. Equipment suppliers benefit when cardiac capability is embedded in broader monitoring workflows rather than positioned only as a standalone specialty purchase.
Weight & Temperature Monitoring
Weight & temperature monitoring accounted for 15.0% of the market in 2025 and is projected to reach USD 213 million by 2035. Its clinical relevance spans routine wellness examinations, perioperative care, hospitalization, and critical-care management. The category retains a stable demand floor because these measurements remain essential across nearly every veterinary encounter.
Neurology
Neurology generated USD 51 million in 2025 and is expected to grow at a 10.0% CAGR (2026–2035). Demand is concentrated in referral centers managing advanced neurological, spinal, and intracranial cases. The segment benefits from greater institutional specialization, although adoption remains dependent on access to trained clinicians, imaging capability, and case volume.
Other Applications
Other applications accounted for 4.0% of the market in 2025 and are projected to reach USD 61 million by 2035. These uses include monitoring associated with emerging specialty disciplines, research protocols, and less standardized clinical settings. Their contribution is shaped by targeted workflow needs rather than broad-based equipment standardization.
By Animal Type
Small Companion Animals
Small companion animals generated USD 397 million in 2025 and are projected to account for 63.1% of the market by 2035. Dogs and cats create the broadest procedural demand base, supported by frequent veterinary visits and owner expectations for clinical-grade care. This concentration makes small-animal workflows central to product design, sensor validation, and the commercial strategy of most monitoring-equipment suppliers.
Dogs
Dogs generated USD 250 million in 2025 and are projected to reach USD 643 million by 2035. Canine monitoring demand spans general practice, dentistry, orthopedic surgery, oncology, and specialty medicine, supporting use across virtually every major product type. The diversity of canine procedures helps sustain both routine equipment replacement and adoption of higher-function systems in referral settings.
Cats
Cats accounted for 17.0% of the market in 2025 and are forecast to grow at a 9.6% CAGR (2026–2035). Feline patients are increasingly included in more rigorous pre-anesthetic, intraoperative, and recovery monitoring protocols. Their distinct physiologic requirements favor equipment and sensors that have been validated for reliable use in smaller patients.
Other Companion Animals
Other companion animals represented 6.0% of the market in 2025 and are projected to reach USD 94 million by 2035. Rabbits, ferrets, guinea pigs, and similar animals require practices to adapt monitoring approaches to smaller body mass and species-specific physiology. Growth in exotic-capable clinics is expanding the need for flexible platforms that can accommodate this more complex patient mix.
Large Animals
Large animals accounted for 28.0% of the market in 2025 and are projected to reach USD 416 million by 2035. Equine care remains the primary source of demand, while livestock, ambulatory, and food-animal practice add a distinct requirement for portable and durable equipment. Field-based procedures create operational conditions that favor robust systems with practical battery life and transportability.
Equines
Equines generated USD 128 million in 2025 and are projected to represent 18.9% of the market by 2035. Equine anesthesia and surgical care require continuous surveillance under conditions that can differ substantially from small-animal hospital practice. Equipment must withstand larger patient mass, demanding procedural environments, and the need for reliable operation in both field and hospital settings.
Other Large Animals
Other large animals accounted for 8.0% of the market in 2025 and are projected to represent 7.1% by 2035. Demand is linked to food-animal practice, reproductive procedures, institutional research, and episodic surgical care. Purchasing decisions typically emphasize ruggedness, serviceability, and fit with mobile clinical workflows.
Exotic Animals
Exotic animals generated USD 65 million in 2025 and are forecast to grow at a 10.5% CAGR (2026–2035). Birds, reptiles, and zoo animals present unusually varied physiologic profiles that can limit the usefulness of standard monitoring assumptions. The category therefore rewards suppliers that can demonstrate species-aware performance and support clinicians working in specialized settings.
By Price Tier
Economic
The economic tier generated USD 269 million in 2025 and is projected to account for 40.2% of the market by 2035. It serves the extensive base of primary-care clinics and budget-conscious purchasers that prioritize dependable core functions, accessible maintenance, and manageable total ownership costs. This tier remains strategically important in emerging markets and geographically dispersed practice networks.
Mid-Range
The mid-range tier held a 35.0% market share in 2025 and is projected to reach USD 544 million by 2035. It addresses clinics seeking integrated capabilities such as basic connectivity, data logging, and capnography without the capital intensity of hospital-grade systems. Competitive pressure in this tier will increasingly center on the quality of clinical functionality delivered at a practical price point.
Premium
The premium tier generated USD 148 million in 2025 and is forecast to grow at a 10.5% CAGR (2026–2035). Demand is concentrated in specialty hospitals, university facilities, research institutions, and referral networks where accountability and procedural complexity justify investment in advanced sensor integration and connected workflows. Suppliers in this tier must pair technical differentiation with implementation, training, and service support.
By End Use
Veterinary Hospitals
Veterinary hospitals generated USD 288 million in 2025 and are projected to account for 46.9% of the market by 2035. Hospitals are the leading channel for premium multi-parameter, anesthesia, and specialty systems because they manage a higher concentration of surgical, emergency, and referral cases. Network expansion and consolidation can further standardize procurement and increase the value of interoperable equipment portfolios.
Veterinary Clinics & Diagnostic Centers
Veterinary clinics & diagnostic centers accounted for 38.0% of the market in 2025 and are projected to reach USD 578 million by 2035. Clinics remain the largest volume buyers of economic and mid-range platforms, while diagnostic centers are broadening monitoring capability alongside expanded point-of-care services. Their buying decisions are especially sensitive to usability, capital budgets, and the ability to fit new equipment into established workflows.
Research Institutes
Research institutes generated USD 77 million in 2025 and are expected to grow at a 9.5% CAGR (2026–2035). Veterinary universities, preclinical research programs, and animal-health research facilities require monitoring systems for surgical research, anesthetic protocol development, and longitudinal studies. Procurement can be grant-driven, but these settings create sustained demand for reliable, specialized equipment.
Other End Use
Other end uses accounted for 5.0% of the market in 2025 and are projected to reach USD 78 million by 2035. Mobile practices, shelter medicine, and government animal-care facilities are increasingly able to adopt portable systems as device size, battery capability, and connectivity improve. These settings represent an important route for monitoring beyond conventional hospital infrastructure.
GMI Analyst View
We believe the fastest-growing opportunities are emerging where monitoring becomes embedded in institutional care models rather than purchased as an isolated device. Specialty hospitals, referral networks, and research settings can convert higher clinical complexity into repeatable procurement demand, while connected platforms are making the distinction between procedure-room and recovery monitoring progressively less rigid.
Veterinary Monitoring Equipment Market Regional Analysis
North America Veterinary Monitoring Equipment Market Analysis
The veterinary monitoring equipment market in North America generated USD 250 million in 2025 and is projected to reach USD 575 million by 2035. Mature companion-animal care, established referral infrastructure, and a deep base of specialty hospitals support demand for advanced equipment. Consolidated practice networks are also increasing the importance of standardized procurement, service coverage, and integration across multi-site clinical operations.
U.S.
The U.S. generated USD 217 million in 2025 and is projected to reach USD 491 million by 2035. It is the region's principal market for advanced monitoring platforms, including multi-parameter systems, connected devices, and central-station workflows. Corporate hospital groups and large referral facilities provide a concentrated channel for suppliers that can meet requirements for training, uptime, and interoperability.
Canada
Canada accounted for 13.2% of the North American market in 2025 and is forecast to expand at a 9.8% CAGR (2026–2035). Growth is supported by urban specialty-care expansion and an increasing emphasis on standardized clinical monitoring. The market favors suppliers that can serve both companion-animal hospitals and established equine practices across a geographically dispersed care network.
Europe Veterinary Monitoring Equipment Market Analysis
Europe held a 27.0% market share in 2025 and is projected to reach USD 405 million by 2035. Mature companion-animal markets, high practitioner density in Western Europe, and established clinical protocols support recurring demand for monitoring systems. Growth is broadening as specialty care capacity develops in additional markets, although purchasing conditions remain differentiated by local care models and capital budgets.
Germany
Germany generated USD 44 million in 2025 and is projected to account for 24.7% of the European market by 2035. A dense base of referral hospitals, university facilities, and technologically capable general practices supports demand across price tiers. The country's institutional depth favors vendors able to provide validated products and dependable technical support.
United Kingdom
The United Kingdom generated USD 36 million in 2025 and is expected to grow at a 9.2% CAGR (2026–2035). Specialty-hospital capacity, corporate practice ownership, and established insurance-supported care contribute to demand for mid-range and premium monitoring equipment. Clinical education and professional expectations also reinforce the use of structured perioperative monitoring.
France
France accounted for 16.2% of the European market in 2025 and is projected to reach USD 69 million by 2035. Academic veterinary medicine and metropolitan referral care underpin adoption of advanced systems. The market's opportunity lies in hospitals and specialty practices that are formalizing anesthesia and recovery protocols around continuous monitoring.
Italy
Italy generated USD 19 million in 2025 and is projected to reach USD 44 million by 2035. Independent clinics and general-practice buyers remain central to demand, with emerging referral networks adding higher-specification requirements. Equipment suppliers must balance capability with affordability and accessible service in a market where ownership-cost considerations remain prominent.
Spain
Spain represented 9.2% of the European market in 2025 and is forecast to grow at a 9.1% CAGR (2026–2035). Urban companion-animal ownership and clinic expansion are supporting adoption, particularly for mid-range platforms. The continued development of specialty care should increase demand for integrated anesthesia and respiratory monitoring.
Netherlands
The Netherlands accounted for 5.8% of the European market in 2025 and is expected to grow at an 8.7% CAGR (2026–2035). High practitioner density, strong clinical standards, and a specialized equine-care base support steady equipment demand. Compact geography can also make training, distribution, and after-sales service more efficient for suppliers.
Asia Pacific Veterinary Monitoring Equipment Market Analysis
The veterinary monitoring equipment market in Asia Pacific generated USD 141 million in 2025 and is forecast to advance at an 11.1% CAGR (2026–2035). Urban companion-animal ownership, expanding specialty hospitals, and investment in veterinary infrastructure are creating a broad regional demand base. The market combines fast-growing emerging care systems with mature markets that support replacement demand and earlier adoption of connected technologies.
China
China generated USD 51 million in 2025 and is projected to account for 40.0% of the Asia Pacific market by 2035. Large urban pet populations and increasing hospital specialization are strengthening demand for internationally specified monitoring systems. Domestic manufacturers are also expanding their product offerings, intensifying competition in accessible and mid-range equipment.
Japan
Japan accounted for 22.0% of the Asia Pacific market in 2025 and is projected to reach USD 75 million by 2035. Its mature companion-animal market and aging pet population support demand for cardiac, neurological, and multi-parameter monitoring. Advanced technology adoption provides a favorable setting for equipment that can integrate into sophisticated clinical workflows.
India
India generated USD 25 million in 2025 and is forecast to grow at a 12.0% CAGR (2026–2035). Companion-animal adoption, veterinary education, and livestock-health investment are enlarging the addressable care infrastructure. Entry-level and mid-range systems are likely to remain important as hospitals and clinics build foundational monitoring capacity.
Australia
Australia represented 11.3% of the Asia Pacific market in 2025 and is projected to account for 9.4% by 2035. Its relative share moderates as faster-growing regional markets expand, but the country retains a mature base of companion-animal and equine demand. Replacement cycles, clinical standards, and specialist care continue to support reliable equipment spending.
South Korea
South Korea generated USD 13 million in 2025 and is expected to grow at a 10.2% CAGR (2026–2035). Urban pet ownership and rising specialty-care capacity are supporting demand for higher-function monitoring platforms. Cardiology and neurology-oriented services offer a further avenue for suppliers serving referral and teaching-hospital settings.
Latin America Veterinary Monitoring Equipment Market Analysis
The veterinary monitoring equipment market in Latin America generated USD 45 million in 2025 and is projected to reach USD 115 million by 2035. Urban companion-animal ownership and private clinic investment are enlarging the market, while affordability and limited insurance penetration constrain premium-system adoption. Economic and mid-range equipment remain important because buyers must balance clinical requirements with capital discipline.
Brazil
Brazil generated USD 26 million in 2025 and is projected to account for 60.9% of the Latin American market by 2035. Its scale and concentration of advanced veterinary care in major cities make it the region's central opportunity for global suppliers. Hospital expansion is supporting demand for multi-parameter and anesthesia monitoring, while a broad clinic base sustains volume for more accessible systems.
Mexico
Mexico accounted for 22.2% of the Latin American market in 2025 and is forecast to grow at a 9.6% CAGR (2026–2035). Urban clinic networks and access to North American distribution channels support a widening product range for veterinary buyers. Mid-range platforms are well positioned where clinics seek better monitoring capability without a premium-system investment.
Argentina
Argentina accounted for 13.3% of the Latin American market in 2025 and is projected to represent 11.3% by 2035. Economic volatility can complicate capital-equipment purchasing, but a well-established veterinary profession and sizable companion-animal population preserve demand for essential monitoring tools. Suppliers that offer dependable servicing and flexible channel arrangements can be better positioned in this environment.
Middle East & Africa Veterinary Monitoring Equipment Market Analysis
The veterinary monitoring equipment market in Middle East & Africa generated USD 32 million in 2025 and is expected to grow at a 10.4% CAGR (2026–2035). Growth is led by investment in veterinary infrastructure in GCC markets, while African markets offer longer-term potential as access to basic and specialty veterinary services improves. Purchasing remains heterogeneous, with premium demand concentrated in better-resourced urban centers.
UAE
The UAE accounted for 25.0% of the Middle East & Africa market in 2025 and is forecast to grow at an 11.5% CAGR (2026–2035). Investment in premium veterinary facilities, expatriate companion-animal ownership, and demand for international-standard care support adoption of advanced monitoring systems. The market is particularly receptive to suppliers that can deliver premium service and rapid technical support.
Saudi Arabia
Saudi Arabia generated USD 7 million in 2025 and is projected to account for 23.3% of the Middle East & Africa market by 2035. Expanding service infrastructure and changing companion-animal care patterns are creating new demand beyond traditional equine and livestock applications. The opportunity depends on the pace at which facility development is translated into staffed, clinically active veterinary capacity.
South Africa
South Africa generated USD 6 million in 2025 and is projected to account for 18.6% of the Middle East & Africa market by 2035. Its established veterinary profession, equine care, and wildlife medicine create differentiated demand for portable and durable monitoring systems. Field-based workflows increase the value of equipment that can perform reliably outside conventional hospital environments.
GMI Analyst View
We expect Asia Pacific to remain the most consequential arena for incremental demand because its care infrastructure is expanding alongside changing expectations among urban pet owners. In mature regions, supplier advantage will increasingly depend on the ability to support standardized procurement across hospital networks, not simply on the breadth of a device catalog.
Veterinary Monitoring Equipment Market Share & Competitive Landscape
The veterinary monitoring equipment market exhibits a moderately concentrated competitive structure, with Mindray Animal Health, IDEXX Laboratories, Midmark, Heska Corporation, and Bionet collectively accounting for approximately 45.1% of global market revenue in 2025. Market competition is driven by product accuracy, veterinary-specific monitoring capabilities, portfolio breadth, software integration, distribution reach, and after-sales service support. While leading suppliers benefit from established veterinary customer relationships and comprehensive monitoring portfolios, regional manufacturers and specialty providers continue to compete through cost-effective solutions, niche applications, and localized service capabilities.
Other participants, including Avante Animal Health, Bionet America, Burtons Veterinary, Dextronix, Digicare Animal Health, Hallmarq Veterinary Imaging, ICU Medical, Masimo, Medtronic, Nonin, Vetland Medical, and Vetronic Services, compete through specialized capabilities, channel depth, product reliability, and access to discrete veterinary care settings. The market's fragmented portion leaves room for focused suppliers, but qualification requirements and after-sales support can be material barriers to scale.
Recent Industry Developments
In December 2025, Schwarzman Animal Medical Center completed an 83,000-square-foot, USD 125 million transformation in New York City, expanding emergency and specialty clinical capacity. The development illustrates how investment in high-acuity veterinary hospitals can broaden the institutional setting for specialty-grade monitoring equipment and related workflow infrastructure [5]Schwarzman Animal Medical Center. "Schwarzman Animal Medical Center Completes a Four-Year, 83,000 Square-Foot, and $125 Million Transformation." prnewswire.com.
In January 2026, Mindray and Medtronic North America expanded their strategic patient-monitoring partnership into U.S. ambulatory surgery centers. The collaboration combines technologies including BIS brain monitoring, regional oximetry, pulse oximetry, and capnography within Mindray monitoring platforms, reinforcing the importance of integrated monitoring architectures in procedural care [6]Mindray. "Medtronic and Mindray North America Broaden Strategic Partnership Beyond Hospitals to Ambulatory Surgery Centers Across the U.S." mindray.com.
In June 2026, Danaher completed its acquisition of Masimo Corporation. The transaction places Masimo's noninvasive monitoring and connectivity capabilities within a larger life-sciences and diagnostics organization, with potential implications for capital availability, technology development, and commercial reach in veterinary monitoring channels [7]Masimo. "Danaher Completes Acquisition of Masimo Corporation." masimo.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →